---
figid: PMC3594951__IJE2013-803171.001
figtitle: This figure schematically shows the tyrosine kinase receptors, such as RET,
  EGFR, FGFR, MET, KIT, VEGFR, PDGFR, and some of their downstream effectors
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC3594951
filename: IJE2013-803171.001.jpg
figlink: /pmc/articles/PMC3594951/figure/fig1/
number: F1
caption: This figure schematically shows the tyrosine kinase receptors, such as RET,
  EGFR, FGFR, MET, KIT, VEGFR, PDGFR, and some of their downstream effectors. The
  two most important oncogenic signaling pathways are PI3K/AKT/mTOR and Ras/Raf/MEK/ERK.
  The activation of the pathways may transduce different transcription factors and
  induce tumor and endothelial cell proliferation, survival, migration, with subsequent
  tumor growth, lymphangiogenesis/angiogenesis, and metastasis. Moreover, the main
  tyrosine kinase inhibitors and their targets are shown.
papertitle: Cellular Signaling Pathway Alterations and Potential Targeted Therapies
  for Medullary Thyroid Carcinoma.
reftext: Serena Giunti, et al. Int J Endocrinol. 2013;2013:803171.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6872017
figid_alias: PMC3594951__F1
figtype: Figure
redirect_from: /figures/PMC3594951__F1
ndex: b2cffcdd-df34-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3594951__IJE2013-803171.001.html
  '@type': Dataset
  description: This figure schematically shows the tyrosine kinase receptors, such
    as RET, EGFR, FGFR, MET, KIT, VEGFR, PDGFR, and some of their downstream effectors.
    The two most important oncogenic signaling pathways are PI3K/AKT/mTOR and Ras/Raf/MEK/ERK.
    The activation of the pathways may transduce different transcription factors and
    induce tumor and endothelial cell proliferation, survival, migration, with subsequent
    tumor growth, lymphangiogenesis/angiogenesis, and metastasis. Moreover, the main
    tyrosine kinase inhibitors and their targets are shown.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - blo
  - Ret
  - reticulated
  - reti
  - rets
  - ras
  - Ras64B
  - Ras85D
  - hop
  - bsk
  - Pten
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Stat92E
  - Dsor1
  - Mtk
  - IKKepsilon
  - key
  - IKKbeta
  - Mtor
  - Tor
  - Erk7
  - rl
  - Dif
  - dl
  - Rel
  - MKP-4
  - p38b
  - EGFR
  - KIT
  - KDR
  - FLT4
  - PDGFRB
  - PDGFRA
  - RET
  - KRAS
  - HRAS
  - NRAS
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - Vandetanib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
